DK0892636T3 - Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger - Google Patents

Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger

Info

Publication number
DK0892636T3
DK0892636T3 DK97902574T DK97902574T DK0892636T3 DK 0892636 T3 DK0892636 T3 DK 0892636T3 DK 97902574 T DK97902574 T DK 97902574T DK 97902574 T DK97902574 T DK 97902574T DK 0892636 T3 DK0892636 T3 DK 0892636T3
Authority
DK
Denmark
Prior art keywords
pct
ophthalmic
tamarind seed
date aug
sec
Prior art date
Application number
DK97902574T
Other languages
Danish (da)
English (en)
Inventor
Marco Fabrizio Saettone
Susi Burgalassi
Boris Giannaccini
Enrico Boldrini
Pietro Bianchini
Giulio Luciani
Original Assignee
Farmigea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea Spa filed Critical Farmigea Spa
Application granted granted Critical
Publication of DK0892636T3 publication Critical patent/DK0892636T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
DK97902574T 1996-02-05 1997-02-04 Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger DK0892636T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000075A IT1283911B1 (it) 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
PCT/IT1997/000026 WO1997028787A1 (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide

Publications (1)

Publication Number Publication Date
DK0892636T3 true DK0892636T3 (da) 2001-12-17

Family

ID=11403863

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902574T DK0892636T3 (da) 1996-02-05 1997-02-04 Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger

Country Status (14)

Country Link
US (1) US6056950A (it)
EP (1) EP0892636B1 (it)
JP (1) JP3872515B2 (it)
KR (1) KR100430260B1 (it)
AT (1) ATE204745T1 (it)
AU (1) AU1617897A (it)
CA (1) CA2245617C (it)
DE (1) DE69706410T2 (it)
DK (1) DK0892636T3 (it)
EA (1) EA001067B1 (it)
ES (1) ES2164327T3 (it)
IT (1) IT1283911B1 (it)
PT (1) PT892636E (it)
WO (1) WO1997028787A1 (it)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291892B1 (it) 1997-04-24 1999-01-21 Alessandro Lambiase Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella
ATE250923T1 (de) 1997-07-29 2003-10-15 Alcon Lab Inc Galaktomannanpolymere und borat enthaltende augenarzneimittel
IT1305294B1 (it) 1999-01-29 2001-05-04 Alessandro Lambiase Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
ES2255987T3 (es) 1999-03-01 2006-07-16 Milcin Therapeutics Llc Preparaciones oftalmicas conteniendo mucina.
AU2002230504A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic irrigating solution adapted for use in lasik surgery
AU2002232437A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
EP1363600B1 (en) * 2001-02-15 2008-10-01 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6465506B2 (en) * 2001-02-22 2002-10-15 Ophthalmic Research Associates, Inc. Instillation techniques for ophthalmic agents to enhance treatment effect
CN1522161A (zh) 2001-06-29 2004-08-18 �Ȱ�ά����ķ�ɷݹ�˾ 批量高压灭菌方法
US20040266725A1 (en) * 2001-08-10 2004-12-30 Toray Industries., Inc. Polysaccharide-containing compositions and use thereof
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
EP2130541A3 (en) 2002-07-29 2013-12-18 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
DE602004032446D1 (de) 2003-08-07 2011-06-09 Rigel Pharmaceuticals Inc 2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
WO2005014046A2 (en) * 2003-08-07 2005-02-17 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using the same
US20060241037A1 (en) * 2003-10-03 2006-10-26 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
EP1683528A4 (en) * 2003-11-10 2011-07-27 Toray Industries POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
US20050210732A1 (en) * 2004-03-26 2005-09-29 Guerin John W Crank bait tail
JP4395016B2 (ja) * 2004-06-29 2010-01-06 日清オイリオグループ株式会社 ゲル状吸水用組成物
US7726809B2 (en) * 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ITRM20050447A1 (it) * 2005-08-19 2007-02-20 Anabasis S R L Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson.
CA2642229C (en) 2006-02-24 2015-05-12 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
JP5134778B2 (ja) * 2006-03-10 2013-01-30 日清オイリオグループ株式会社 ゲル組成物及び該ゲル組成物を使用したパック化粧料
EP2420505A1 (en) 2006-11-21 2012-02-22 Rigel Pharmaceuticals, Inc. Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
GB0719969D0 (en) 2007-10-12 2007-11-21 Cambridge Entpr Ltd Substance monitoring and control in human or animal bodies
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
CA2746810C (en) 2008-12-30 2017-03-14 Rigel Pharmaceuticals, Inc. Pyrimidinediamine kinase inhibitors
JP5802136B2 (ja) 2009-01-23 2015-10-28 ライジェル ファーマシューティカルズ， インコーポレイテッド Ｊａｋ経路の阻害のための組成物および方法
CN102405044A (zh) 2009-02-06 2012-04-04 南加利福尼亚大学 含有单萜的治疗组合物
BR112012002001A2 (pt) 2009-07-28 2016-05-10 Rigel Pharmaceuticals Inc método para tratar uma doença e/ou distúrbio do olho, formulação farmacêutica, e, kit
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
CN102892289B (zh) 2010-03-03 2015-03-25 尼昂克技术公司 包含单萜的药物组合物
JP5266430B2 (ja) 2010-04-24 2013-08-21 ヴィアメット ファーマスーティカルズ，インコーポレイテッド 金属酵素阻害化合物
SG185694A1 (en) 2010-05-24 2012-12-28 Indena Spa Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
KR101878450B1 (ko) 2010-05-24 2018-07-13 인데나 에스.피.에이 미생물 감염의 치료에서의 사용을 위한 타마린드 씨 다당류
JP5620168B2 (ja) * 2010-06-30 2014-11-05 Ｄｓｐ五協フード＆ケミカル株式会社 キシログルカン−カチオン複合体及びそれを含有する安定化組成物
ES2560954T3 (es) * 2010-07-12 2016-02-23 Zambon S.P.A. Polímero polisacárido de las semillas del árbol tamarindo para la utilización en el tratamiento de la tos seca
AU2011282742B2 (en) 2010-07-28 2015-08-27 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
CN103168018B (zh) 2010-08-27 2015-10-21 尼昂克技术公司 包含poh衍生物的药物组合物
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
CA2816088A1 (en) 2010-10-28 2012-05-03 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
WO2012064943A2 (en) 2010-11-13 2012-05-18 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
EP2651864B1 (en) 2010-12-17 2016-07-13 Neonc Technologies Inc. Methods and devices for using isoperillyl alcohol
WO2012116254A2 (en) 2011-02-25 2012-08-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chrysophaentin analogs that inhibit ftsz protein
ITMI20110583A1 (it) 2011-04-08 2012-10-09 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
RU2463022C1 (ru) * 2011-04-19 2012-10-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения больных с синдромом "сухого глаза"
EP2701722A4 (en) 2011-04-28 2014-12-31 Univ Southern California CANCEROUS MARKERS OF HUMAN SUPPRESSIVE MYELOID CELLS
CN103764646A (zh) 2011-06-19 2014-04-30 威尔金制药有限公司 金属酶抑制剂化合物
EA025406B1 (ru) 2011-06-19 2016-12-30 Ваймет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
KR101964195B1 (ko) 2011-06-23 2019-04-01 비아멧 파마슈티컬즈(엔씨), 인코포레이티드 금속효소 억제제 화합물
PT2741754E (pt) 2011-08-12 2015-09-11 Zambon Spa Utilização de um polímero de polissacárido proveniente das sementes do tamarindeiro na proteção contra danos associados ao tabaco
JP6376550B2 (ja) * 2011-09-07 2018-08-22 千寿製薬株式会社 水性液剤の粘度低下抑制方法
WO2013046059A2 (en) * 2011-09-27 2013-04-04 Sykora Robert C Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
PT2788343T (pt) 2011-12-11 2018-06-01 Viamet Pharmaceuticals Nc Inc Compostos inibidores de metaloenzimas
DK2804858T3 (da) 2012-01-20 2020-03-16 Mycovia Pharmaceuticals Inc Metalloenzym-inhibitorforbindelser
WO2013142038A2 (en) 2012-03-23 2013-09-26 Oxigene, Inc. Compositions and methods for inhibition of cathepsins
US20130310340A1 (en) 2012-05-16 2013-11-21 Rigel Pharmaceuticals, Inc. Method of treating muscular degradation
WO2015001087A2 (en) * 2013-07-05 2015-01-08 Therakine Biodelivery Gmbh Drug-delivery composition for topical applications and injections and ophtalmic formulations, method for manufacturing thereof, and methods for delivery a drug-delivery composition
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
EP3348273B8 (en) 2014-04-15 2019-09-18 Devintec, Sagl Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
KR20170131405A (ko) 2015-02-12 2017-11-29 네온씨 테크놀로지스, 아이엔씨. 페릴릴 알코올 유도체를 포함하는 의약 조성물
EP3103438B1 (en) 2015-06-11 2018-11-14 Novintethical Pharma SA Topical nasal compositions containing xyloglucans for use as decongestans
JP7116945B2 (ja) * 2015-07-13 2022-08-12 株式会社 東北テクノアーチ 視神経保護用組成物
EP3719016A1 (en) 2015-08-04 2020-10-07 Rigel Pharmaceuticals, Inc. Benzazole compounds and methods for making and using the compounds
WO2017025983A1 (en) 2015-08-07 2017-02-16 Council Of Scientific & Industrial Research A lubricant formulation of carbamoylethyl katira and a process for preparation thereof
KR102240920B1 (ko) 2015-12-30 2021-04-16 브이피에스-3, 엘엘씨 금속 효소 억제 화합물
US10710983B2 (en) 2016-06-27 2020-07-14 Rigel Pharmaceuticals, Inc. 2,4-diamino-pyrimidine compounds and method for making and using the compounds
WO2018081294A1 (en) 2016-10-26 2018-05-03 Rigel Pharmaceuticals, Inc. Pyrazole amide compounds as irak inhibitors
CA3041587A1 (en) 2016-10-26 2018-05-17 Rigel Pharmaceuticals, Inc. Oxazole derivatives for use as irak inhibitors and method for their preparation
JP7144411B2 (ja) 2016-11-30 2022-09-29 ネオンク テクノロジーズ インク． ペリリルアルコール－３－ブロモピルベート複合体及びがんの治療方法
EP3562306A4 (en) 2016-12-29 2020-06-24 Selenity Therapeutics (Bermuda), Ltd. METALLOENZYME INHIBITOR COMPOUNDS
DK3562487T3 (da) 2016-12-29 2024-01-02 Ji Xing Pharmaceuticals Hong Kong Ltd Metalloenzyminhibitorforbindelser
JP7167069B2 (ja) 2017-06-29 2022-11-08 ライジェル ファーマシューティカルズ， インコーポレイテッド キナーゼ阻害剤ならびに作製および使用のための方法
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
US20210292410A1 (en) 2017-12-07 2021-09-23 Morphosys Ag Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment
CA3225993A1 (en) 2018-02-08 2019-08-15 University Of Southern California The use of monoterpene, sesquiterpene, or their derivatives to permeabilize the blood brain barrier
PT3788045T (pt) 2018-05-03 2023-06-26 Rigel Pharmaceuticals Inc Compostos inibidores de rip1 e métodos para fazer e usar os mesmos
CA3099037A1 (en) 2018-05-03 2019-11-07 Rigel Pharmaceuticals, Inc. Rip1 inhibitory compounds and methods for making and using the same
WO2020092845A1 (en) 2018-11-01 2020-05-07 Rigel Pharmaceuticals, Inc. Method and composition embodiments for treating acute myeloid leukemia
WO2020243612A1 (en) 2019-05-29 2020-12-03 Rigel Pharmaceuticals, Inc. Method of preventing and treating thrombosis
CN114698370A (zh) 2019-08-08 2022-07-01 里格尔药品股份有限公司 用于治疗细胞因子释放综合征的化合物和方法
CA3147444A1 (en) 2019-08-14 2021-02-18 Rigel Pharmaceuticals, Inc. Method of blocking or ameliorating cytokine release syndrome
EP4003990A1 (en) 2019-08-30 2022-06-01 Rigel Pharmaceuticals, Inc. Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations
TW202122397A (zh) 2019-09-06 2021-06-16 美商雷傑製藥公司 Ｒｉｐ１抑制性化合物及用於製備和使用其之方法
CN114761398A (zh) 2019-09-06 2022-07-15 里格尔药品股份有限公司 杂环rip1激酶抑制剂
JP7395730B2 (ja) 2019-11-07 2023-12-11 ライジェル ファーマシューティカルズ， インコーポレイテッド ヘテロ環式ｒｉｐ１阻害化合物
WO2022187303A1 (en) 2021-03-03 2022-09-09 Rigel Pharmaceuticals, Inc. A method for treating a disease or condition using a pyrazole compound or formulation thereof
TW202300490A (zh) 2021-03-11 2023-01-01 美商雷傑製藥公司 雜環rip1激酶抑制劑
WO2023183377A1 (en) 2022-03-23 2023-09-28 Rigel Pharmaceuticals, Inc. Pyrimid-2-yl-pyrazole compounds as irak inhibitors
WO2023192479A1 (en) 2022-03-31 2023-10-05 Rigel Pharmaceuticals, Inc. Tricyclic irak inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
JPH0748278A (ja) * 1992-06-10 1995-02-21 Taiho Yakuhin Kogyo Kk 鼻腔用粉末製剤

Also Published As

Publication number Publication date
PT892636E (pt) 2002-02-28
JP2000504685A (ja) 2000-04-18
EP0892636A1 (en) 1999-01-27
KR100430260B1 (ko) 2004-07-30
ITRM960075A1 (it) 1997-08-05
ITRM960075A0 (it) 1996-02-05
EP0892636B1 (en) 2001-08-29
WO1997028787A1 (en) 1997-08-14
EA001067B1 (ru) 2000-10-30
CA2245617C (en) 2005-07-12
US6056950A (en) 2000-05-02
IT1283911B1 (it) 1998-05-07
ES2164327T3 (es) 2002-02-16
CA2245617A1 (en) 1997-08-14
KR19990082244A (ko) 1999-11-25
AU1617897A (en) 1997-08-28
EA199800689A1 (ru) 1999-02-25
DE69706410T2 (de) 2002-06-06
ATE204745T1 (de) 2001-09-15
JP3872515B2 (ja) 2007-01-24
DE69706410D1 (de) 2001-10-04

Similar Documents

Publication Publication Date Title
DK0892636T3 (da) Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger
CA2193543C (en) Sodium hyaluronate based ophthalmic formulation for use in eye surgery
DK0744938T3 (da) Flydende oftalmisk afgivelsessystem med vedholdende afgivelse
ES2166905T3 (es) Composiciones que incluyen o-carboxialquilquitosano y metodos de uso en productos oftalmicos.
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
ATE220296T1 (de) Konfekt basierend auf hydrokolloid
MX9708043A (es) Liberacion controlada de farmacos mioticos y midriaticos en la camara anterior.
ATE233083T1 (de) Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen
ATE499106T1 (de) Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
MX9701609A (es) Composicion espesada por un alquileter de polisacarido.
DK0804152T3 (da) Lactulose-pastiller
Esfandiari et al. Effect of glucosamine on intraocular pressure
KR960037046A (ko) 도파민 수용기 자극제를 포함하는 근시 및 녹내장 치료용 안과 제형
BRPI0502198A (pt) hidrogel fluido de goma guar purificada e desproteinada como agente viscoelástico aplicado na viscossuplementação de articulações com osteoartrite